CN109467737B - Method for preparing molecularly imprinted polymer by taking S-2-mercaptopropionic acid as chiral functional monomer - Google Patents

Method for preparing molecularly imprinted polymer by taking S-2-mercaptopropionic acid as chiral functional monomer Download PDF

Info

Publication number
CN109467737B
CN109467737B CN201811112248.1A CN201811112248A CN109467737B CN 109467737 B CN109467737 B CN 109467737B CN 201811112248 A CN201811112248 A CN 201811112248A CN 109467737 B CN109467737 B CN 109467737B
Authority
CN
China
Prior art keywords
molecularly imprinted
imprinted polymer
mips
functional monomer
mercaptopropionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811112248.1A
Other languages
Chinese (zh)
Other versions
CN109467737A (en
Inventor
成会玲
胡德琼
刘迎梅
陈树梁
王朝武
陈云龙
何易
字富庭
胡显智
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming University of Science and Technology
Original Assignee
Kunming University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming University of Science and Technology filed Critical Kunming University of Science and Technology
Priority to CN201811112248.1A priority Critical patent/CN109467737B/en
Publication of CN109467737A publication Critical patent/CN109467737A/en
Application granted granted Critical
Publication of CN109467737B publication Critical patent/CN109467737B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F122/00Homopolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F122/10Esters
    • C08F122/1006Esters of polyhydric alcohols or polyhydric phenols, e.g. ethylene glycol dimethacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/26Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00Foams characterised by the foaming process
    • C08J2201/04Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/044Elimination of an inorganic solid phase
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2335/00Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Derivatives of such polymers
    • C08J2335/02Characterised by the use of homopolymers or copolymers of esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a method for preparing a molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer, belonging to the technical field of functional polymer materials. The method for preparing the molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer comprises the following steps: s-2-mercaptopropionic acid is used as a chiral functional monomer, S-naproxen is used as a template molecule, nano silica gel is used as a substrate, and a sacrificial silica gel framework method is adopted to prepare the molecularly imprinted polymer MIPs. The molecularly imprinted polymer prepared by the method has the characteristics of high imprinting rate and good selective adsorption performance, and can be used for chiral resolution of racemic naproxen.

Description

Method for preparing molecularly imprinted polymer by taking S-2-mercaptopropionic acid as chiral functional monomer
Technical Field
The invention relates to a method for preparing a molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer, belonging to the technical field of functional polymer materials.
Background
In recent years, the nonsteroidal drug Naproxen (alpha-methyl-6-methoxy-2-naphthylacetic acid, Naproxen) has the efficacy of relieving fever and easing pain, and is widely applied in the pharmaceutical industry. The alpha position of the naproxen derivative has a chiral carbon atom, a pair of optically active enantiomers exist, and research shows that R-configuration and S-configuration have different drug effects, and the drug effect of the S-configuration naproxen is 28 times that of the R-configuration. Naproxen is required to be marketed as a single enantiomer in order to reduce the toxic side effects of the isomers on the human body and the amount of the drug, and therefore, chiral resolution of a racemic mixture of naproxen is required.
Compared with other separation systems, molecularly imprinted polymers prepared by Molecular Imprinting Technology (MIT) show promising characteristics, such as low cost, easy synthesis, higher stability to complex chemical and physical environments, and better reusability. Thus, MIPs are widely used in many fields such as purification and separation, chiral recognition, chemical and biological sensing, and catalysis.
The preparation method of the Molecularly Imprinted Polymers (MIPs) comprises the following steps: precipitation polymerization, bulk polymerization, suspension polymerization, surface imprinting, and multi-step swelling polymerization. The sacrificial silica gel skeleton method in the surface imprinting method overcomes the defects that a bulk polymerization method and a precipitation polymerization method are difficult to remove template molecules, the polymer is irregular in shape, the experiment cost is high and the like, and becomes one of the most important methods for preparing the molecularly imprinted polymer. The document CN103193934A adopts a column chromatography silica gel surface molecular imprinting technology to prepare a molecularly imprinted polymer, but the obtained polymer has small specific surface area and low imprinting rate, so that the specific adsorption capacity of the polymer is influenced.
Disclosure of Invention
Aiming at the problems and the defects in the prior art, the invention provides a method for preparing a molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer. The invention takes nano silica gel as a carrier, S-2-mercaptopropionic acid as a chiral functional monomer, and adopts a sacrificial silica gel framework method to prepare the molecularly imprinted polymer, so that the invention has the characteristics of high imprinting rate and good selective adsorption performance, and can be used for chiral resolution of racemic naproxen. The invention is realized by the following technical scheme.
A method for preparing a molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer comprises the following steps: s-2-mercaptopropionic acid is used as a chiral functional monomer, S-naproxen is used as a template molecule, nano silica gel is used as a substrate, and a sacrificial silica gel framework method is adopted to prepare the molecularly imprinted polymer MIPs.
The method comprises the following specific steps:
step 1, preparation of a pre-polymerization solution: completely dissolving S-naproxen in a pore-foaming agent, adding a chiral functional monomer S-2-mercaptopropionic acid, oscillating for 2-3 h, adding a crosslinking agent ethylene glycol dimethacrylate and an initiator azobisisobutyronitrile, and shaking up to form a pre-polymerization solution;
step 2, preparation of MIPs: transferring the prepolymerization solution obtained in the step 1 into an incubator tube filled with nano silica gel, carrying out ultrasonic treatment for 5-10 min, sealing, and carrying out water bath at 60-70 ℃ for 12-24 h to form a block polymer, namely molecularly imprinted polymer MIPs;
step 3, elution of the MIPs: and (3) placing the molecularly imprinted polymer MIPs obtained in the step (2) in a hydrofluoric acid solution to remove a silica gel framework, performing suction filtration, eluting the template molecules by using a mixed solution of methanol and acetic acid with the volume ratio of 9:1, then washing the template molecules to be neutral by using methanol, and performing vacuum drying for 24 hours to obtain the eluted molecularly imprinted polymer MIPs.
The pore-foaming agent in the step 1 is methanol, ethanol, acetonitrile, tetrahydrofuran, dichloromethane or N, N-dimethylformamide.
In the step 1, the molar ratio of S-naproxen, the chiral functional monomer S-2-mercaptopropionic acid and the cross-linking agent ethylene glycol dimethacrylate is 1: 2-8: 10-50.
In the step 1, the molar ratio of S-naproxen to the initiator azobisisobutyronitrile is 1: 0.06-0.12.
The above-mentioned S-naproxen is a commercially available reagent.
The invention has the beneficial effects that:
(1) the method adopts a sacrificial silica gel framework method and takes the nano silica gel as a matrix, and the prepared imprinted polymer has the advantages of large adsorption capacity, good imprinting effect, convenience in elution, high adsorption speed and the like, and solves the problems that the imprinted polymer prepared by the existing method has complicated post-treatment process, cannot be eluted due to too deep or too tight embedding of template ions, leakage in the use process and the like.
(2) The prepared molecularly imprinted polymer has good stability and repeatability, the resolution of racemic naproxen is successfully realized, the resolution factor reaches 2.31, the molecularly imprinted polymer has an obvious resolution effect, is expected to be used for chiral resolution of actual samples, and has a good application prospect.
Detailed Description
The present invention will be further described with reference to the following embodiments.
Example 1
The method for preparing the molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer comprises the following steps: s-2-mercaptopropionic acid is taken as a chiral functional monomer, S-naproxen (S-Npx) is taken as a template molecule, and Nano silica gel (Nano-SiO)215 nm) as a substrate, and preparing the molecularly imprinted polymer MIPs by a sacrificial silica gel framework method.
The method comprises the following specific steps:
step 1, preparation of a pre-polymerization solution: completely dissolving 0.5mmol of S-naproxen in 20mL of pore-foaming agent (methanol), adding 2mmol of chiral functional monomer S-2-mercaptopropionic acid, oscillating for 3h, adding 10mmol of crosslinking agent ethylene glycol dimethacrylate and initiator azobisisobutyronitrile, and shaking up to form a pre-polymerization solution; wherein the molar ratio of the S-naproxen to the chiral functional monomer S-2-mercaptopropionic acid to the crosslinking agent ethylene glycol dimethacrylate is 1:4:20, and the molar ratio of the S-naproxen to the initiator azobisisobutyronitrile is 1: 0.12;
step 2, preparation of MIPs: transferring the prepolymerization solution obtained in the step 1 into an amplex tube filled with nano silica gel (10 g of nano silica gel is filled in a 40mL amplex tube), carrying out ultrasonic treatment for 5min, sealing, and carrying out water bath at 60 ℃ for 24h to form a block polymer, namely Molecularly Imprinted Polymer (MIPs);
step 3, elution of the MIPs: and (3) placing 0.40g of the MIPs obtained in the step (2) in 100mL of hydrofluoric acid solution (the concentration of the hydrofluoric acid solution is 448 g/L) to remove a silica gel framework, performing suction filtration, eluting the template molecules by using 150mL of mixed solution of methanol and acetic acid with the volume ratio of 9:1, washing the template molecules by using methanol until the template molecules are neutral, and performing vacuum drying for 24 hours to obtain the eluted MIPs.
The molecularly imprinted polymer MIPs prepared in the embodiment can adsorb S-naproxen, and the imprinting factor can reach 4.82. And the resolution factor of the molecularly imprinted polymer MIPs reaches 2.31, and the molecularly imprinted polymer MIPs has an obvious resolution effect.
Example 2
The method for preparing the molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer comprises the following steps: s-2-mercaptopropionic acid is taken as a chiral functional monomer, S-naproxen (S-Npx) is taken as a template molecule, and Nano silica gel (Nano-SiO)215 nm) as a substrate, and preparing the molecularly imprinted polymer MIPs by a sacrificial silica gel framework method.
The method comprises the following specific steps:
step 1, preparation of a pre-polymerization solution: completely dissolving 0.5mmol of S-naproxen in 20mL of pore-foaming agent (ethanol), adding 1mmol of chiral functional monomer S-2-mercaptopropionic acid, oscillating for 2 hours, adding 10mmol of cross-linking agent ethylene glycol dimethacrylate and initiator azobisisobutyronitrile, and shaking up to form a pre-polymerization solution; wherein the molar ratio of the S-naproxen to the chiral functional monomer S-2-mercaptopropionic acid to the crosslinking agent ethylene glycol dimethacrylate is 1:2:20, and the molar ratio of the S-naproxen to the initiator azobisisobutyronitrile is 1: 0.06;
step 2, preparation of MIPs: transferring the prepolymerization solution obtained in the step 1 into an amplex tube filled with nano silica gel (10 g of nano silica gel is filled in a 40mL amplex tube), carrying out ultrasonic treatment for 10min, sealing, and carrying out water bath at 70 ℃ for 24h to form a block polymer, namely Molecularly Imprinted Polymer (MIPs);
step 3, elution of the MIPs: and (3) placing 0.33g of the MIPs obtained in the step (2) in 100mL of hydrofluoric acid solution (the concentration of the hydrofluoric acid solution is 448 g/L) to remove a silica gel framework, performing suction filtration, eluting the template molecules by using 150mL of mixed solution of methanol and acetic acid with the volume ratio of 9:1, washing the template molecules by using methanol until the template molecules are neutral, and performing vacuum drying for 24 hours to obtain the eluted MIPs.
The molecularly imprinted polymer MIPs prepared in the embodiment can adsorb S-naproxen, and the imprinting factor can reach 1.18. And the resolution factor of the molecularly imprinted polymer MIPs reaches 1.56, and the molecularly imprinted polymer MIPs has an obvious resolution effect.
Example 3
The molecular imprinting polymerization is prepared by taking S-2-mercaptopropionic acid as a chiral functional monomerA method of making a composition comprising the steps of: s-2-mercaptopropionic acid is taken as a chiral functional monomer, S-naproxen (S-Npx) is taken as a template molecule, and Nano silica gel (Nano-SiO)215 nm) as a substrate, and preparing the molecularly imprinted polymer MIPs by a sacrificial silica gel framework method.
The method comprises the following specific steps:
step 1, preparation of a pre-polymerization solution: completely dissolving 0.5mmol of S-naproxen in 20mL of pore-foaming agent (tetrahydrofuran), adding 4mmol of chiral functional monomer S-2-mercaptopropionic acid, oscillating for 3 hours, adding 5mmol of crosslinking agent ethylene glycol dimethacrylate and initiator azobisisobutyronitrile, and shaking up to form a pre-polymerization solution; wherein the molar ratio of the S-naproxen to the chiral functional monomer S-2-mercaptopropionic acid to the crosslinking agent ethylene glycol dimethacrylate is 1:8:10, and the molar ratio of the S-naproxen to the initiator azobisisobutyronitrile is 1: 0.09;
step 2, preparation of MIPs: transferring the prepolymerization solution obtained in the step 1 into an amplex tube filled with nano silica gel (10 g of nano silica gel is filled in a 40mL amplex tube), carrying out ultrasonic treatment for 5min, sealing, and carrying out water bath at 70 ℃ for 24h to form a block polymer, namely Molecularly Imprinted Polymer (MIPs);
step 3, elution of the MIPs: and (3) placing 0.31g of the MIPs obtained in the step (2) in 100mL of hydrofluoric acid solution (the concentration of the hydrofluoric acid solution is 448 g/L) to remove a silica gel framework, performing suction filtration, eluting the template molecules by using 150mL of mixed solution of methanol and acetic acid with the volume ratio of 9:1, washing the template molecules by using methanol until the template molecules are neutral, and performing vacuum drying for 24 hours to obtain the eluted MIPs.
The molecularly imprinted polymer MIPs prepared in the embodiment can adsorb S-naproxen, and the imprinting factor can reach 1.12. And the resolution factor of the molecularly imprinted polymer MIPs reaches 1.37, and the molecularly imprinted polymer MIPs has an obvious resolution effect.
Example 4
The method for preparing the molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer comprises the following steps: s-2-mercaptopropionic acid is taken as a chiral functional monomer, S-naproxen (S-Npx) is taken as a template molecule, and Nano silica gel (Nano-SiO)215 nm) as matrix, and adopting sacrificial silica gel skeleton method to prepare the molecularly imprinted polymerThe substance MIPs.
The method comprises the following specific steps:
step 1, preparation of a pre-polymerization solution: completely dissolving 0.5mmol of S-naproxen in 20mL of pore-foaming agent (tetrahydrofuran), adding 2mmol of chiral functional monomer S-2-mercaptopropionic acid, oscillating for 3 hours, adding 5mmol of crosslinking agent ethylene glycol dimethacrylate and initiator azobisisobutyronitrile, and shaking uniformly to form a pre-polymerization solution; wherein the molar ratio of the S-naproxen to the chiral functional monomer S-2-mercaptopropionic acid to the crosslinking agent ethylene glycol dimethacrylate is 1:4:10, and the molar ratio of the S-naproxen to the initiator azobisisobutyronitrile is 1: 0.09;
step 2, preparation of MIPs: transferring the prepolymerization solution obtained in the step 1 into an amplex tube filled with nano silica gel (10 g of nano silica gel is filled in a 40mL amplex tube), carrying out ultrasonic treatment for 5min, sealing, and carrying out water bath at 60 ℃ for 12h to form a block polymer, namely Molecularly Imprinted Polymer (MIPs);
step 3, elution of the MIPs: and (3) placing 0.40g of the MIPs obtained in the step (2) in 100mL of hydrofluoric acid solution (the concentration of the hydrofluoric acid solution is 448 g/L) to remove a silica gel framework, performing suction filtration, eluting the template molecules by using 150mL of mixed solution of methanol and acetic acid with the volume ratio of 9:1, washing the template molecules by using methanol until the template molecules are neutral, and performing vacuum drying for 24 hours to obtain the eluted MIPs.
The molecularly imprinted polymer MIPs prepared in the embodiment can adsorb S-naproxen, and the imprinting factor can reach 2.15. And the resolution factor of the molecularly imprinted polymer MIPs reaches 2.06, and the molecularly imprinted polymer MIPs has an obvious resolution effect.
Example 5
The method for preparing the molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer comprises the following steps: s-2-mercaptopropionic acid is taken as a chiral functional monomer, S-naproxen (S-Npx) is taken as a template molecule, and Nano silica gel (Nano-SiO)215 nm) as a substrate, and preparing the molecularly imprinted polymer MIPs by a sacrificial silica gel framework method.
The method comprises the following specific steps:
step 1, preparation of a pre-polymerization solution: completely dissolving 0.5mmol of S-naproxen in 20mL of pore-foaming agent (dichloromethane), adding 2mmol of chiral functional monomer S-2-mercaptopropionic acid, oscillating for 3 hours, adding 20mmol of crosslinking agent ethylene glycol dimethacrylate and initiator azobisisobutyronitrile, and shaking up to form a pre-polymerization solution; wherein the molar ratio of the S-naproxen to the chiral functional monomer S-2-mercaptopropionic acid to the crosslinking agent ethylene glycol dimethacrylate is 1:4:40, and the molar ratio of the S-naproxen to the initiator azobisisobutyronitrile is 1: 0.09;
step 2, preparation of MIPs: transferring the prepolymerization solution obtained in the step 1 into an amplex tube filled with nano silica gel (10 g of nano silica gel is filled in a 40mL amplex tube), carrying out ultrasonic treatment for 10min, sealing, and carrying out water bath at 70 ℃ for 24h to form a block polymer, namely Molecularly Imprinted Polymer (MIPs);
step 3, elution of the MIPs: and (3) placing 0.38g of the MIPs obtained in the step (2) in 100mL of hydrofluoric acid solution (the concentration of the hydrofluoric acid solution is 448 g/L) to remove a silica gel framework, performing suction filtration, eluting the template molecules by using 150mL of mixed solution of methanol and acetic acid with the volume ratio of 9:1, washing the template molecules to be neutral by using methanol, and performing vacuum drying for 24h to obtain the eluted MIPs.
The molecularly imprinted polymer MIPs prepared in the embodiment can adsorb S-naproxen, and the imprinting factor can reach 1.22. And the resolution factor of the molecularly imprinted polymer MIPs reaches 1.69, and the molecularly imprinted polymer MIPs has an obvious resolution effect.
Example 6
The method for preparing the molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer comprises the following steps: s-2-mercaptopropionic acid is taken as a chiral functional monomer, S-naproxen (S-Npx) is taken as a template molecule, and Nano silica gel (Nano-SiO)215 nm) as a substrate, and preparing the molecularly imprinted polymer MIPs by a sacrificial silica gel framework method.
The method comprises the following specific steps:
step 1, preparation of a pre-polymerization solution: completely dissolving 0.5mmol of S-naproxen in 20mL of pore-foaming agent (N, N-dimethylformamide), adding 2mmol of chiral functional monomer S-2-mercaptopropionic acid, oscillating for 2.5h, adding 25mmol of crosslinking agent ethylene glycol dimethacrylate and initiator azobisisobutyronitrile, and shaking up to form a pre-polymerization solution; wherein the molar ratio of the S-naproxen to the chiral functional monomer S-2-mercaptopropionic acid to the crosslinking agent ethylene glycol dimethacrylate is 1:4:50, and the molar ratio of the S-naproxen to the initiator azobisisobutyronitrile is 1: 0.09;
step 2, preparation of MIPs: transferring the prepolymerization solution obtained in the step 1 into an amplex tube filled with nano silica gel (10 g of nano silica gel is filled in a 40mL amplex tube), carrying out ultrasonic treatment for 7min, sealing, and carrying out water bath at 65 ℃ for 18h to form a block polymer, namely Molecularly Imprinted Polymer (MIPs);
step 3, elution of the MIPs: and (3) placing 0.40g of the MIPs obtained in the step (2) in 100mL of hydrofluoric acid solution (the concentration of the hydrofluoric acid solution is 448 g/L) to remove a silica gel framework, performing suction filtration, eluting the template molecules by using 150mL of mixed solution of methanol and acetic acid with the volume ratio of 9:1, washing the template molecules by using methanol until the template molecules are neutral, and performing vacuum drying for 24 hours to obtain the eluted MIPs.
The molecularly imprinted polymer MIPs prepared in the embodiment can adsorb S-naproxen, and the imprinting factor can reach 1.28. And the resolution factor of the molecularly imprinted polymer MIPs reaches 1.78, and the molecularly imprinted polymer MIPs has an obvious resolution effect.
In the above examples, the reagents are analytically pure reagents except for the reagents of the specified labeled concentrations.
While the present invention has been described in detail with reference to the specific embodiments thereof, the present invention is not limited to the embodiments described above, and various changes can be made without departing from the spirit of the present invention within the knowledge of those skilled in the art.

Claims (4)

1. A method for preparing a molecularly imprinted polymer by taking S-2-mercaptopropionic acid as a chiral functional monomer is characterized by comprising the following steps: s-2-mercaptopropionic acid is used as a chiral functional monomer, S-naproxen is used as a template molecule, nano silica gel is used as a substrate, and a sacrificial silica gel framework method is adopted to prepare Molecularly Imprinted Polymers (MIPs);
the method comprises the following specific steps:
step 1, preparation of a pre-polymerization solution: completely dissolving S-naproxen in a pore-foaming agent, adding a chiral functional monomer S-2-mercaptopropionic acid, oscillating for 2-3 h, adding a crosslinking agent ethylene glycol dimethacrylate and an initiator azobisisobutyronitrile, and shaking up to form a pre-polymerization solution;
step 2, preparation of MIPs: transferring the prepolymerization solution obtained in the step 1 into an incubator tube filled with nano silica gel, carrying out ultrasonic treatment for 5-10 min, sealing, and carrying out water bath at 60-70 ℃ for 12-24 h to form a block polymer, namely molecularly imprinted polymer MIPs;
step 3, elution of the MIPs: and (3) placing the molecularly imprinted polymer MIPs obtained in the step (2) in a hydrofluoric acid solution to remove a silica gel framework, performing suction filtration, eluting the template molecules by using a mixed solution of methanol and acetic acid with the volume ratio of 9:1, then washing the template molecules to be neutral by using methanol, and performing vacuum drying for 24 hours to obtain the eluted molecularly imprinted polymer MIPs.
2. The method for preparing the molecularly imprinted polymer by using S-2-mercaptopropionic acid as a chiral functional monomer according to claim 1, wherein the method comprises the following steps: the pore-foaming agent in the step 1 is methanol, ethanol, acetonitrile, tetrahydrofuran, dichloromethane or N, N-dimethylformamide.
3. The method for preparing the molecularly imprinted polymer by using S-2-mercaptopropionic acid as a chiral functional monomer according to claim 1, wherein the method comprises the following steps: in the step 1, the molar ratio of S-naproxen, the chiral functional monomer S-2-mercaptopropionic acid and the cross-linking agent ethylene glycol dimethacrylate is 1: 2-8: 10-50.
4. The method for preparing the molecularly imprinted polymer by using S-2-mercaptopropionic acid as a chiral functional monomer according to claim 1, wherein the method comprises the following steps: in the step 1, the molar ratio of S-naproxen to the initiator azobisisobutyronitrile is 1: 0.06-0.12.
CN201811112248.1A 2018-09-25 2018-09-25 Method for preparing molecularly imprinted polymer by taking S-2-mercaptopropionic acid as chiral functional monomer Active CN109467737B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811112248.1A CN109467737B (en) 2018-09-25 2018-09-25 Method for preparing molecularly imprinted polymer by taking S-2-mercaptopropionic acid as chiral functional monomer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811112248.1A CN109467737B (en) 2018-09-25 2018-09-25 Method for preparing molecularly imprinted polymer by taking S-2-mercaptopropionic acid as chiral functional monomer

Publications (2)

Publication Number Publication Date
CN109467737A CN109467737A (en) 2019-03-15
CN109467737B true CN109467737B (en) 2021-07-16

Family

ID=65663282

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811112248.1A Active CN109467737B (en) 2018-09-25 2018-09-25 Method for preparing molecularly imprinted polymer by taking S-2-mercaptopropionic acid as chiral functional monomer

Country Status (1)

Country Link
CN (1) CN109467737B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101864021A (en) * 2010-05-14 2010-10-20 江苏大学 Preparation method of nanometer silicon gel surface gastrodin molecular engram polymers
CN102127187A (en) * 2010-12-29 2011-07-20 天津工业大学 Naproxen molecular imprinting hydrogel and preparation method thereof
CN102974323A (en) * 2012-11-20 2013-03-20 红云红河烟草(集团)有限责任公司 Preparation method of absorbent for selectively reducing phenol content in smoke of cigarette
CN104275155A (en) * 2014-10-28 2015-01-14 武汉大学 Preparation method of novel cadmium ion imprinting magnetic mesoporous silica gel solid-phase extracting agent as well as application of preparation method
CN106432645A (en) * 2016-09-26 2017-02-22 山东省分析测试中心 'Mercapto-gold' modified silica-gel surface sudan molecularly imprinted material as well as preparation method and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101864021A (en) * 2010-05-14 2010-10-20 江苏大学 Preparation method of nanometer silicon gel surface gastrodin molecular engram polymers
CN102127187A (en) * 2010-12-29 2011-07-20 天津工业大学 Naproxen molecular imprinting hydrogel and preparation method thereof
CN102974323A (en) * 2012-11-20 2013-03-20 红云红河烟草(集团)有限责任公司 Preparation method of absorbent for selectively reducing phenol content in smoke of cigarette
CN104275155A (en) * 2014-10-28 2015-01-14 武汉大学 Preparation method of novel cadmium ion imprinting magnetic mesoporous silica gel solid-phase extracting agent as well as application of preparation method
CN106432645A (en) * 2016-09-26 2017-02-22 山东省分析测试中心 'Mercapto-gold' modified silica-gel surface sudan molecularly imprinted material as well as preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Jun Haginaka et al.."Uniformly sized molecularly imprinted polymer for (S)-naproxen: Retention and molecular recognition properties in aqueous mobile phase".《Journal of Chromatography A》.2001,第913卷141-146. *
李辉等."牺牲硅胶骨架法制备盐酸黄连素印迹聚合物及其性能研究".《功能材料》.2012,第43卷(第6期), *
马娟娟."S-蔡普生印迹聚合物材料的合成及性能研究".《中国优秀硕士学位论文全文数据库工程科技I辑》.2004,(第04期), *

Also Published As

Publication number Publication date
CN109467737A (en) 2019-03-15

Similar Documents

Publication Publication Date Title
Liu et al. A review on the use of ionic liquids in preparation of molecularly imprinted polymers for applications in solid-phase extraction
CN109569026B (en) Preparation of chromatographic stationary phase with porous frame material as matrix for chiral separation
CN109260967B (en) Metal organic framework composite membrane and preparation method and application thereof
Ding et al. A metal organic framework-functionalized monolithic column for enantioseparation of six basic chiral drugs by capillary electrochromatography
US9643173B2 (en) Temperature responsive adsorbent having a strong cation exchange group and method for producing the same
Hong et al. Preparation of graphene oxide-modified affinity capillary monoliths based on three types of amino donor for chiral separation and proteolysis
CN107469653B (en) Synthesis method of molecular imprinting composite membrane for enriching and separating norfloxacin
Gao et al. Preparation of surface imprinted material of single enantiomer of mandelic acid with a new surface imprinting technique and study on its chiral recognition and resolution properties
CN108273477B (en) Porous polyion liquid adsorbent and application thereof
CN104892868A (en) Silica gel surface molecularly imprinted polymer with specific adsorption of DEHP and preparation method and application thereof
CN109772178B (en) Preparation method and application of pyrimethamine molecularly imprinted composite membrane based on click chemistry double-sided loading
Pu et al. Progress of molecular imprinting technique for enantioseparation of chiral drugs in recent ten years
CN106334343B (en) A kind of preparation method and applications of agar sugar bonding silica-gel hydridization integral post
CN104530314A (en) Preparation method and application of bionic temperature-sensitive molecular engram composite film
Yan et al. Polydopamine-based multilevel molecularly imprinted nanocomposite membranes comprising metal organic frameworks for selective recognition and separation
Zhu et al. Direct growth of boronate based shikimic acid imprinted polymer on porous substrate surface: A stable membrane for specific molecular separation
CN113398776B (en) Preparation method and application of bionic MOFs (metal organic frameworks) -based double-layer molecular imprinting nano composite membrane based on dual continuous imprinting system
CN109467737B (en) Method for preparing molecularly imprinted polymer by taking S-2-mercaptopropionic acid as chiral functional monomer
CN111440354B (en) Preparation method and application of bisphenol A molecularly imprinted composite membrane with through hierarchical pore structure
CN102962040A (en) Molecularly imprinted membrane for chiral separation and preparation method thereof
CN109554826B (en) Nano electro-spinning membrane with efficient selectivity on amino acid and preparation method thereof
CN106866900A (en) A kind of photoresponse molecularly imprinted material on surface and its preparation method and application
CN113368708B (en) Preparation method and application of suction filtration type double-layer molecular imprinting nano composite membrane based on multiple nano composite imprinting system
CN103191706B (en) Preparation method of 2,5- dyhydroxyl benzoic acid molecule blotting membrane and application of 2,5- dyhydroxyl benzoic acid molecule blotting membrane
CN113368706B (en) Preparation method and application of bionic suction filtration type double-layer molecularly imprinted nanofiber composite membrane based on poly-dopamine imprinting strategy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant